Characterization of MHC/peptide complexes refolded by a one-step ion-exchange chromatography

Journal of Immunological Methods

Volumn 369, Issue 1-2, 2011, Pages 81-90

  Shen, Chuanlai ^a   He, Yong ^a   Meng, Fanyan ^a   Cheng, Kai ^a   Zhang, Daoping ^a   Miao, Fengqin ^a   Zhang, Jianqiong ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Dilution refolding; MHC peptide complex; On column refolding; T cell detection

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE COMPLEX; PEPTIDES AND PROTEINS; RECOMBINANT PROTEIN; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DILUTION; HEAVY CHAIN; ION EXCHANGE CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; PROTEIN REFOLDING; T LYMPHOCYTE;

ANIMALS; CHROMATOGRAPHY, ION EXCHANGE; HISTOCOMPATIBILITY ANTIGENS; MALE; MICE; PEPTIDES; PROTEIN REFOLDING; RECEPTORS, ANTIGEN, T-CELL;

EID: 79958839676     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.04.014     Document Type: Article

References (23)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996, 274:94-96.
2. Caballero A., Fernandez N., Lavado R., Bravo M.J., Miranda J.M., Alonso A. Tolerogenic response: allorecognition pathways. Transpl Immunol 2006, 17:3-6.
3. Cukalac, T., Valkenburg, S.A., La Gruta, N.L., Turner, S.J., Doherty, P.C. and Kedzierska, K. Multiplexed combinatorial tetramer staining in a mouse model of virus infection. J Immunol Methods 360, 157-61.
4. Dimopoulos N., Jackson H.M., Ebert L., Guillaume P., Luescher I.F., Ritter G., Chen W. Combining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cells. J Immunol Methods 2009, 340:90-94.
5. Flinta C., Persson B., Jornvall H., von Heijne G. Sequence determinants of cytosolic N-terminal protein processing. Eur J Biochem 1986, 154:193-196.
6. Garboczi D.N., Hung D.T., Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A 1992, 89:3429-3433.
7. Hess P.R., Barnes C., Woolard M.D., Johnson M.D., Cullen J.M., Collins E.J., Frelinger J.A. Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin. Blood 2007, 109:3300-3307.
8. Hirel P.H., Schmitter M.J., Dessen P., Fayat G., Blanquet S. Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc Natl Acad Sci U S A 1989, 86:8247-8251.
9. Kuhns S.T., Pease L.R. A region of conformational variability outside the peptide-binding site of a class I MHC molecule. J Immunol 1998, 161:6745-6750.
10. Li J.J., Venkataramana M., Sanyal S., Janson J.C., Su Z.G. Immobilized beta-cyclodextrin polymer coupled to agarose gel properly refolding recombinant Staphylococcus aureus elongation factor-G in combination with detergent micelle. Protein Expr Purif 2006, 45:72-79.
11. Meng F., Shen C., He Y., Miao F., Zhang J. Cloning and expression of three peptide-linked beta2-microglobulin molecules in Escherichia coli with an isocaudamer technique. Biotechnol Lett 2009, 31:831-836.
12. Ministry of Science and Technology of China, 2006. The guide for the care and use of laboratory animals. http://www.most.gov.cn/fggw/zfwj/zfwj2006/200609/t20060930_54389.htm.
13. Neely A., Garcia-Olivares J., Voswinkel S., Horstkott H., Hidalgo P. Folding of active calcium channel beta(1b)-subunit by size-exclusion chromatography and its role on channel function. J Biol Chem 2004, 279:21689-21694.
14. Oelke M., Maus M.V., Didiano D., June C.H., Mackensen A., Schneck J.P. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat Med 2003, 9:619-624.
15. Ren D., Wang F., He X., Jiang L., Li D., Ying H., Sun S. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli. Protein Expr Purif 2006, 50:171-178.
16. Schutz C., Fleck M., Mackensen A., Zoso A., Halbritter D., Schneck J.P., Oelke M. Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells. Blood 2008, 111:3546-3552.
17. Shen C., Chang C.C., Zhang J., Guo W., Xia L., Meng F., Xie W. Structural and functional characterization of peptide-beta2m fused HLA-A2/MART1(27-35) complexes. Biochem Biophys Res Commun 2006, 342:57-65.
18. Shen C., Zhang J., Xia L., Meng F., Xie W. Induction of tumor antigen-specific cytotoxic T cell responses in naive mice by latex microspheres-based artificial antigen-presenting cell constructs. Cell Immunol 2007, 247:28-35.
19. Tafuro S., Meier U.C., Dunbar P.R., Jones E.Y., Layton G.T., Hunter M.G., Bell J.I., McMichael A.J. Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules. Eur J Immunol 2001, 31:440-449.
20. Ugel S., Zoso A., De Santo C., Li Y., Marigo I., Zanovello P., Scarselli E., Cipriani B., Oelke M., Schneck J.P., Bronte V. In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. Cancer Res 2009, 69:9376-9384.
21. Vallejo L.F., Rinas U. Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact 2004, 3:11.
22. Wang F., Liu Y., Li J., Ma G., Su Z. On-column refolding of consensus interferon at high concentration with guanidine-hydrochloride and polyethylene glycol gradients. J Chromatogr A 2006, 1115:72-80.
23. Yang J., James E., Roti M., Huston L., Gebe J.A., Kwok W.W. Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals. Int Immunol 2009, 21:63-71.